Bhairavi Tolani

Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors

Hittu Matta, Bhairavi Tolani, Timothy J. Triche et al. · Oncogene · 2015 · 114 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Primary Effusion Lymphoma +8

Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors

Bhairavi Tolani, Vasu Punj, Hittu Matta et al. · Oncogene · 2013 · 98 citations · Full text

Lymphoid Neoplasia, Medicine, Immunology +9

Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice

Bhairavi Tolani, Anna Celli, Yanmin Yao et al. · Nature Biotechnology · 2022 · 34 citations · Full text

Membrane-bound full-length Sonic Hedgehog identifies cancer stem cells in human non-small cell lung cancer

Etienne Giroux‐Leprieur, Bhairavi Tolani, Hui Li et al. · Oncotarget · 2017 · 26 citations · Full text

Kaposi’s Sarcoma Associated Herpesvirus Encoded Viral FLICE Inhibitory Protein K13 Activates NF-κB Pathway Independent of TRAF6, TAK1 and LUBAC

Hittu Matta, Gopalakrishnan Ramakrishnan, Ciaren Graham et al. · PLoS ONE · 2012 · 25 citations · Full text